CBD and Nerve Sensitivity: What the Preclinical Study on an Animal Model Reveals

The mechanisms of interaction between cannabinoids and the nervous system are the subject of extensive scientific research worldwide. Among these works, a study conducted by a team of Brazilian researchers from the University of São Paulo (Ribeirão Preto) focused on the role of cannabidiol (CBD) in modulating nerve sensitivity in animals.

A protocol focused on the animal model

Published by the Faculty of Philosophy, Sciences, and Letters, this experiment aimed to observe the response to mechanical stimuli in adult male Wistar rats modeled for diabetes. The subjects showed an alteration in the tactile sensitivity threshold (mechanical allodynia), a phenomenon frequently studied in the context of diabetes-related nerve complications.

During the protocol, researchers administered CBD at different doses (0.1, 0.3, and 3 mg/kg) in two ways:

• Acute administration: Doses of 0.3 and 3 mg/kg showed a significant increase in the mechanical tolerance threshold in subjects, without affecting their locomotor abilities.
• Prolonged (subchronic) administration: Over a period of 14 days, daily application of CBD induced a sustained decrease in excessive sensitivity in the animals.

The involvement of the serotonergic system

To understand the mode of action of CBD, the scientific team tested several receptor blockers (antagonists). While inhibition of classic cannabinoid receptors (CB1 and CB2) did not change the results, blocking serotonin 5-HT1A receptors neutralized the observed effect.

Analyses revealed that treated subjects showed preserved serotonin levels in the spinal cord. According to the researchers' conclusions, the positive impact measured in this study would therefore primarily rely on the activation of the serotonergic system via these 5-HT1A receptors.

What is the scope of these scientific data?

While these preclinical results provide valuable data on the biological functioning of receptors, it is important to maintain a clear distinction between fundamental research and public use:

Disclaimer: Results observed in laboratory animal models cannot be directly extrapolated to humans. CBD is not a medicine and should under no circumstances replace medical treatment. To learn more about the overall action of cannabinoids, you can read our guide to understanding the role of the endocannabinoid system or consult our selection of CBD products for relaxation.

By shedding light on the molecular pathways of CBD, this work nevertheless opens new avenues of understanding for the scientific community.